Market Research Logo

Les Laboratoires Servier SAS - Product Pipeline Review - 2016

Les Laboratoires Servier SAS - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Les Laboratoires Servier SAS - Product Pipeline Review - 2016’, provides an overview of the Les Laboratoires Servier SAS’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Les Laboratoires Servier SAS, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Les Laboratoires Servier SAS
  • The report provides overview of Les Laboratoires Servier SAS including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Les Laboratoires Servier SAS’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Les Laboratoires Servier SAS’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Les Laboratoires Servier SAS’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Les Laboratoires Servier SAS
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Les Laboratoires Servier SAS’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Les Laboratoires Servier SAS Snapshot
Les Laboratoires Servier SAS Overview
Key Information
Key Facts
Les Laboratoires Servier SAS - Research and Development Overview
Key Therapeutic Areas
Les Laboratoires Servier SAS - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Pipeline Products Glance
Les Laboratoires Servier SAS - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Les Laboratoires Servier SAS - Drug Profiles
(amlodipine besylate + perindopril)
Product Description
Mechanism of Action
R&D Progress
ivabradine hydrochloride
Product Description
Mechanism of Action
R&D Progress
(amlodipine besylate + indapamide + perindopril)
Product Description
Mechanism of Action
R&D Progress
(atorvastatin calcium + perindopril)
Product Description
Mechanism of Action
R&D Progress
(indapamide + perindopril)
Product Description
Mechanism of Action
R&D Progress
lucitanib
Product Description
Mechanism of Action
R&D Progress
S-38093
Product Description
Mechanism of Action
R&D Progress
S-38844
Product Description
Mechanism of Action
R&D Progress
S-47445
Product Description
Mechanism of Action
R&D Progress
S-49076
Product Description
Mechanism of Action
R&D Progress
NMSP-153
Product Description
Mechanism of Action
R&D Progress
S-055746
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Mcl-1 for Cancer
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit Insulin-Regulated AminoPeptidase for Alzheimer’s Disease
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Cancer
Product Description
Mechanism of Action
R&D Progress
Drugs for Triple Negative Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Central Nervous System Disorders
Product Description
Mechanism of Action
R&D Progress
Les Laboratoires Servier SAS - Pipeline Analysis
Les Laboratoires Servier SAS - Pipeline Products by Target
Les Laboratoires Servier SAS - Pipeline Products by Route of Administration
Les Laboratoires Servier SAS - Pipeline Products by Molecule Type
Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action
Les Laboratoires Servier SAS - Recent Pipeline Updates
Les Laboratoires Servier SAS - Dormant Projects
Les Laboratoires Servier SAS - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
agomelatine
terutroban
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Les Laboratoires Servier SAS, Key Information
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS - Pipeline by Indication, 2016
Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2016
Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2016
Les Laboratoires Servier SAS - Combination Treatment Modalities in Pipeline, 2016
Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2016
Les Laboratoires Servier SAS - Partnered Products/ Combination Treatment Modalities, 2016
Les Laboratoires Servier SAS - Pre-Registration, 2016
Les Laboratoires Servier SAS - Phase III, 2016
Les Laboratoires Servier SAS - Phase II, 2016
Les Laboratoires Servier SAS - Phase I, 2016
Les Laboratoires Servier SAS - Preclinical, 2016
Les Laboratoires Servier SAS - Discovery, 2016
Les Laboratoires Servier SAS - Pipeline by Target, 2016
Les Laboratoires Servier SAS - Pipeline by Route of Administration, 2016
Les Laboratoires Servier SAS - Pipeline by Molecule Type, 2016
Les Laboratoires Servier SAS - Pipeline Products by Mechanism of Action, 2016
Les Laboratoires Servier SAS - Recent Pipeline Updates, 2016
Les Laboratoires Servier SAS - Dormant Developmental Projects,2016
Les Laboratoires Servier SAS - Discontinued Pipeline Products, 2016
Les Laboratoires Servier SAS, Other Locations
Les Laboratoires Servier SAS, Subsidiaries
List of Figures
Les Laboratoires Servier SAS - Pipeline by Top 10 Indication, 2016
Les Laboratoires Servier SAS - Pipeline by Stage of Development, 2016
Les Laboratoires Servier SAS - Monotherapy Products in Pipeline, 2016
Les Laboratoires Servier SAS - Combination Treatment Modalities in Pipeline, 2016
Les Laboratoires Servier SAS - Partnered Products in Pipeline, 2016
Les Laboratoires Servier SAS - Pipeline by Top 10 Target, 2016
Les Laboratoires Servier SAS - Pipeline by Route of Administration, 2016
Les Laboratoires Servier SAS - Pipeline by Molecule Type, 2016
Les Laboratoires Servier SAS - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report